Bacteriology of hidradenitis suppurativa - Which antibiotics are the treatment of choice?

Acta Dermato-Venereologica

Volumn 94, Issue 6, 2014, Pages 699-702

  Matusiak, Łukasz ^a   Bieniek, Andrzej ^a   Szepietowski, Jacek C ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Acne inversa; Antibiotics; Bacteria; Hidradenitis suppurativa; Treatment

Indexed keywords

ACETYLSPIRAMYCIN; AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; CEFACLOR; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LINCOMYCIN; LYMECYCLINE; METRONIDAZOLE; OXACILLIN; PEFLOXACIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; RIFAMPICIN; ROXITHROMYCIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL FLORA; BACTERIOLOGY; BACTERIUM CULTURE; BACTERIUM ISOLATE; DERMATOLOGIST; EVALUATION STUDY; FEMALE; HUMAN; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCRIPTION; STAPHYLOCOCCUS; SUPPURATIVE HIDRADENITIS; ANTIBIOTIC RESISTANCE; CLINICAL PRACTICE; DRUG USE; HIDRADENITIS SUPPURATIVA; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG PRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION REVIEW; FEMALE; FLUOROQUINOLONES; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; PHYSICIAN'S PRACTICE PATTERNS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907984206     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1841     Document Type: Article

References (28)

1. Jemec GBE. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996; 35: 191-194.
2. Wang B, Yang W, Wen W, Sun J, Su B, Liu B, et al. Gammasecretase gene mutations in familial acne inversa. Science 2010; 330: 1065.
3. Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa and associated factors: still unsolved problems. J Am Acad Dermatol 2009; 61: 362-365.
4. von Laffert M, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol 2010; 19: 533-537.
5. Sellheyer K, Krahl D. Hidradenitis suppurativa is acne inversa. An appeal to finally abandon a misnomer. Int J Dermatol 2005; 44: 535-540.
6. Wolk K, Warszawska K, Hoeflich C, Witte E, Schneider-Burrus S, Witte K, et al. Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol 2011; 186: 1228-1239.
7. Oliveira SH, Canetti C, Ribeiro RA, Cunha FQ. Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells. Inflammation 2008; 31: 36-46.
8. Zouboulis CC, Bechara FG, Fritz K, Kurzen H, Liakou AI, Marsch WC, et al. S1 guideline for the treatment of hidradenitis suppurativa/acne inversa* (number ICD-10 L73.2). J Dtsch Dermatol Ges 2012;10 Suppl 5: S1-S31.
9. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009; 60: 539-561.
10. Alhusayen R, Shear NH. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say? Am J Clin Dermatol 2012; 13: 283-291.
11. Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology 2009; 219: 148-154.
12. van der Zee HH, Boer J, Prens EP, Jemec GB. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology 2009; 219: 143-147.
13. Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 1998; 39: 971-974.
14. Join-Lambert O, Coignard H, Jais JP, Guet-Revillet H, Poirée S, Fraitag S, et al. Efficacy of rifampin-moxifloxacinmetronidazole combination therapy in hidradenitis suppurativa. Dermatology 2011; 222: 49-58.
15. Poli F, Jemec GB, Revuz J. Clinical presentation. In: Jemec GBE, Revuz J, Leyden JJ, editors. Hidradenitis suppurativa. Heidelberg: Springer, 2006: p. 11-24.
16. Thakuria B, Lahon K. The beta lactam antibiotics as an empirical therapy in a developing country: An update on their current status and recommendations to counter the resistance against them. J Clin Diagn Res 2013; 7: 1207-1214.
17. Kozuszko S, Białucha A, Bogiel T, Gospodarek E. [High level of aminoglycoside resistance among Enterococcus faecalis and Enterococcus faecium strains]. Med Dosw Mikrobiol 2011; 63: 105-113 (in Polish).
18. Sartorius K, Killasli H, Oprica C, Sullivan A, Lapins J. Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment. Br J Dermatol 2012; 166: 879-883.
19. Lapins J, Jarstrand C, Emtestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol 1999; 140: 90-95.
20. Brook I, Frazier EH. Aerobic and anaerobic microbiology of axillary hidradenitis suppurativa. J Med Microbiol 1999; 48: 103-105.
21. Jemec GB, Faber M, Gutschik E, Wendelboe P. The bacteriology of hidradenitis suppurativa. Dermatology 1996; 193: 203-206.
22. von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002; 2: 677-685.
23. Kurzen H, Kurokawa I, Jemec GB, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, et al. What causes hidradenitis suppurativa? Exp Dermatol 2008; 17: 455-456.
24. Revuz J. Les traitements antibiotiques dans l'hidradénite suppurée-maladie de Verneuil. Ann Dermatol Venereol 2012; 139: 532-541.
25. Bettoli V, Zauli S, Borghi A, Toni G, Minghetti S, Ricci M, et al. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients. J Eur Acad Dermatol Venereol 2014; 28: 125-126.
26. Mendonça CO, Griffiths CE. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol 2006; 154: 977-978.
27. Ochsendorf F. Systemic antibiotic therapy of acne vulgaris. J Dtsch Dermatol Ges 2006; 4: 828-841.
28. Wortsman X, Revuz J, Jemec GB. Lymph nodes in hidradenitis suppurativa. Dermatology 2009; 219: 22-24.